Status:
COMPLETED
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Transgender Persons
Hormone Replacement Therapy
Eligibility:
All Genders
18+ years
Brief Summary
This study will find out what the reference intervals are for common blood tests in transgender people taking hormone therapy. Reference intervals help doctors interpret blood test results. They are ...
Eligibility Criteria
Inclusion
- Transgender or nonbinary people.
- Aged 18 or older.
- Taking testosterone or oestrogen therapy.
- For 12 months or more.
- Having routine hormone therapy monitoring at the clinic.
Exclusion
- Unable to give informed consent (including participants who cannot communicate in English).
- History of chronic liver disease, chronic kidney disease, diabetes, or severe cardiovascular disease (including myocardial infection, deep vein thrombosis, stroke and pulmonary embolism).
- Blood test results that indicate severe disease.
- Pregnant or within one year after childbirth.
- Other conditions which could put participants at risk by participating, or which could influence the results of the study.
Key Trial Info
Start Date :
April 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 14 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04478760
Start Date
April 13 2021
End Date
May 14 2024
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caldecot Centre, King's College Hospital, 15-22 Caldecot Road
London, United Kingdom, SE5 9RS